Targeting

Authors :: Lina, Hu
Xuanye, Zhang
Huifeng, Li
Suxia, Lin
Shengbing, Zang
Source :: Cancers. 14(22)
Publication Year :: 2022
Abstract: Angioimmunoblastic T-cell lymphoma (AITL), a type of malignant lymphoma with unique genomic aberrations, significant clinicopathological features, and poor prognosis, is characterized by immune system dysregulation. Recent sequencing studies have identified recurrent mutations and interactions in tet methylcytosine dioxygenase 2 (

Tools